Financials data is unavailable for this security.
View more
Year on year PureTech Health PLC 's revenues fell -78.68% from 15.62m to 3.33m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 50.35m to a larger loss of 65.70m.
| Gross margin | -- |
|---|---|
| Net profit margin | -19,222.22% |
| Operating margin | -29,152.56% |
| Return on assets | -14.13% |
|---|---|
| Return on equity | -19.88% |
| Return on investment | -16.35% |
More ▼
Cash flow in USDView more
In 2023, PureTech Health PLC increased its cash reserves by 27.50%, or 41.22m. Cash Flow from Financing totalled 78.14m or 2,346.58% of revenues. In addition the company used 105.92m for operations while cash from investing totalled 68.99m.
| Cash flow per share | -3.15 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in USDView more
| Current ratio | 3.68 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0761 |
|---|---|
| Total debt/total capital | 0.0728 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -34.80%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -80.86 |
